Life Sciences in Focus: Areas of Opportunity
LSX Investor Perception Survey 2019

In this extract from the LSX Investor Perception Survey 2019, respondents identify the life science sub-sectors, therapeutic areas, and geographical markets that they believe provide the greatest investment prospects. The 3rd annual LSX Investor Perception Survey tracks sentiment, aims, and preferences among the life science investment community. 

Download the white paper to:

  • Learn how respondents expect the biotech, medtech, medical devices and digital health sectors to perform over the year ahead.
  • Discover the regional innovations and markets that investors are most excited about.
  • Read commentary and insights from Daniel O’Mahony, Partner at Seroba Life Sciences, John Cassidy, Investment Associate at Arix Bioscience plc, Tara Raveendran, Healthcare Analyst at Shore Capital, and Robert James, Managing Partner at Sixth Element Capital.

Enter your details here to receive the white paper

Formerly Known as Blog Resize

LSX (formerly Biotech and Money) is an influential community of senior life science decision makers. Through our impactful events, powerful thought leadership content and unique networking opportunities, we exist to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.